(E)-N-(2-Fluorophenyl)-1-(2-methylpropane-2-sulfonyl)methanecarbohydrazonoyl cyanide

Catalog No. :
ACIFKE877
CAS No. :
241127-16-2
Molecular Formula :
C13H16FN3O2S
Molecular Weight :
297.36

IUPAC Name:(E)-2-(tert-butylsulfonyl)-N-(2-fluorophenyl)acetohydrazonoyl cyanide

(E)-N-(2-Fluorophenyl)-1-(2-methylpropane-2-sulfonyl)methanecarbohydrazonoyl cyanide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$574.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N-(2-Fluorophenyl)-1-(2-methylpropane-2-sulfonyl)methanecarbohydrazonoyl cyanide
IUPAC Name(E)-2-(tert-butylsulfonyl)-N-(2-fluorophenyl)acetohydrazonoyl cyanide
MDL No.MFCD00664056
Molecular FormulaC13H16FN3O2S
Molecular Weight297.36
SMILESCC(C)(C)S(=O)(=O)C/C(C#N)=N/NC1=CC=CC=C1F
InChI KeyPVNQYVXKFSYRMB-MHWRWJLKSA-N
Synonym2-(TERT-BUTYLSULFONYL)-2-[2-(2-FLUOROPHENYL)HYDRAZONO]ACETONITRILE;Acetonitrile, 2-[(1,1-dimethylethyl)sulfonyl]-2-[2-(2-fluorophenyl)hydrazinylidene]-
CAS No.241127-16-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIFKE877 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIFKE877 route product structure diagram
    ACIFKE877241127-16-2
Inquiry

2. ACIFKE877 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZLWH982 route compound structure diagram
    ACZLWH9822924-15-4 In Stock
  4. Then
  5. ACIFKE877 route product structure diagram
    ACIFKE877241127-16-2
Inquiry

Comments (0)